These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 4145107)

  • 1. Large-scale production of pertussis vaccine by serial subculture technic.
    Csizér Z; Joó I
    Zentralbl Bakteriol Orig A; 1972 Jul; 221(1):59-64. PubMed ID: 4145107
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of culture methods on the biological activities of Bordetella pertussis].
    Hirayanagi F
    Nihon Saikingaku Zasshi; 1969 Jan; 24(1):8-14. PubMed ID: 4306072
    [No Abstract]   [Full Text] [Related]  

  • 3. [Development of a fermentation process in the production of pertussis vaccine].
    Recamier L; Medina A; Rodríguez H
    Salud Publica Mex; 1981; 23(6):563-73. PubMed ID: 6278655
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of Bordetella strains used in the production of anti-pertussis vaccine in stationary culture].
    Castillejos Carmona R; González Pacheco M
    Salud Publica Mex; 1981; 23(6):549-53. PubMed ID: 6278653
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of HBP-2 and FGP-1 culture media in the production of Bordetella pertussis by fermentation].
    Medina García A; Martín Escobar TA; Reyes ET
    Salud Publica Mex; 1981; 23(6):575-84. PubMed ID: 6278656
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative analysis of a Bordetella pertussis patient isolated strain and classical strains used in the pertussis vaccine.
    Pereira A; Pereira AS; Moreira-Filho CA; Bando SY; Tambourgi DV
    Vaccine; 2005 Jul; 23(34):4353-8. PubMed ID: 16005744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid and accurate typing of Bordetella pertussis targeting genes encoding acellular vaccine antigens using real time PCR and High Resolution Melt analysis.
    Chan WF; Maharjan RP; Reeves PR; Sintchenko V; Gilbert GL; Lan R
    J Microbiol Methods; 2009 Jun; 77(3):326-9. PubMed ID: 19341769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key points for the development of mouse immunogenicity test as potency assay for acellular pertussis vaccines.
    André M; Poirier B; Bornstein N; Marmonier D; El Zaouk A; Fuchs F
    Biologicals; 2000 Dec; 28(4):217-25. PubMed ID: 11237357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability in derivative strains of Bordetella pertussis.
    Parker CD; Doyle S; Field LH; Hewlett E
    Dev Biol Stand; 1980; 45():119-27. PubMed ID: 6249689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semicontinuous cultivation of Bordetella pertussis.
    Stránský V; Stejskal A; Stejskal V
    Prog Immunobiol Stand; 1967; 3():266-8. PubMed ID: 4314428
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental relation between histamine-sensitizing factor and the protective antigen of Bordetella pertussis].
    Jiménez Paredes J; Ruiz Puente J; González Pacheco M
    Salud Publica Mex; 1981; 23(6):621-9. PubMed ID: 6278660
    [No Abstract]   [Full Text] [Related]  

  • 12. Vaccine production as a unit process.
    van Hemert P
    Prog Ind Microbiol; 1974; 13():151-271. PubMed ID: 4373785
    [No Abstract]   [Full Text] [Related]  

  • 13. [Initial studies for the development of processes in the production of bacterial vaccines by agitator culture].
    Medina García A; Gómez Reyes I
    Salud Publica Mex; 1981; 23(6):555-62. PubMed ID: 6278654
    [No Abstract]   [Full Text] [Related]  

  • 14. Further contributions to an improved pertussis vaccine: II. New findings in the development of a pertussis vaccine.
    Robbel L; Hungerer KD; Aktories K
    Behring Inst Mitt; 1984 Nov; (76):110-2. PubMed ID: 6098261
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative study of the potency of the pertussis component in DPT vaccine produced in stationary culture and by fermentation].
    Galicia O; Villalva H; Pérez A; Pérez S; Medina A
    Salud Publica Mex; 1981; 23(6):607-11. PubMed ID: 6278658
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation between optical density and viable germ count during cultivation of B. pertussis.
    Csizér Z; Pusztai Z; Joó I
    Zentralbl Bakteriol Orig; 1971; 216(2):215-8. PubMed ID: 4325114
    [No Abstract]   [Full Text] [Related]  

  • 17. IFN-gamma-mediated protection against intracerebral challenge with Bordetella pertussis in mice.
    Sakurai S; Kamachi K; Konda T; Komuro K; Uchida T
    Jpn J Med Sci Biol; 1997 Feb; 50(1):35-43. PubMed ID: 9354968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bordetella pertussis strain variation and evolution postvaccination.
    Kallonen T; He Q
    Expert Rev Vaccines; 2009 Jul; 8(7):863-75. PubMed ID: 19538113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunologic reaction of Bordetella pertussis and leukocytic reaction in mice].
    Walecki H; Sitek K
    Med Dosw Mikrobiol; 1966; 18(2):111-5. PubMed ID: 4287625
    [No Abstract]   [Full Text] [Related]  

  • 20. Considerations on the sensitization properties of Bordetella pertussis.
    Kirchev P; Vesselinova H; Boshkov B; Galabov S
    Nauchni Tr Vissh Med Inst Sofiia; 1969; 48(1):59-63. PubMed ID: 4191303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.